Novel drug delivery platform Colorcon
Location: United States, Massachusetts, Milton
Employees: 1-10
Total raised: $53.4M
Investors 1
| Date | Name | Website |
| - | Touchdown ... | touchdownv... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 07.07.2025 | Series A | $38M | - |
| 16.01.2023 | - | $15.4M | - |
Mentions in press and media 7
| Date | Title | Description |
| 09.07.2025 | Syntis Bio Secures $38M Series A, Accelerates Oral Therapy Pipeline | Syntis Bio, a Boston biopharma, secured $38M Series A funding led by Cerberus Ventures. An additional $5M from NIH non-dilutive grants was also obtained. This substantial capital propels the development of oral therapies for obesity, diabet... |
| 07.07.2025 | Syntis Bio raises $38 million | Syntis Bio, Syntis Bio Founded: 2022 Headquarters: Boston, Massachusetts, United States Total Funding: $53.37M See full company profile "> a Boston-based obesity, diabetes, and rare diseases oral therapies developer, announced the c... |
| 01.07.2025 | Top 10 Startup and Tech Funding News – July 1, 2025 | It’s Tuesday, July 1, 2025, and we’re back with your daily breakdown of startup and tech funding moves. Today’s deals span early-stage moonshots and late-stage growth bets—from robotics and longevity biotech to climate tech and crypto tradi... |
| 01.07.2025 | Syntis Bio Closes $38M Series A Financing | Syntis Bio, a Boston, MA-based clinical-stage biopharmaceutical company developing oral therapies for obesity, diabetes and rare diseases, raised $38M in Series A funding. The round was led by Cerberus Ventures with participation from new i... |
| 01.07.2025 | Syntis Bio Raises $33M Oversubscribed Series A | BOSTON, MA, Syntis Bio announced today the close of a $33 million oversubscribed Series A financing. >> Click here for more funding data on Syntis Bio >> To export Syntis Bio funding data to PDF and Excel, click here Syntis Bio... |
| - | Syntis Bio | “Home - Syntis” |
| - | Syntis Bio | “Syntis” |